A narrative review of the evidence regarding the role of inflammation in the pathophysiology of coronary heart disease and depression is presented. As a common pathogenic factor, inflammation could explain the frequent association of both diseases. We discuss the benefit of exercise and diet modifications in both conditions and the effectiveness and safety of selective serotonin reuptake inhibitors. Finally, we recommend screening for depressive symptoms in coronary patients and the search of cardiovascular risk factors in people with depression.